These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
661 related articles for article (PubMed ID: 12561022)
1. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology. Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor. Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888 [TBL] [Abstract][Full Text] [Related]
3. Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features. Mai KT; Kohler DM; Roustan Delatour NL; Veinot JP Pathol Res Pract; 2006; 202(12):863-8. PubMed ID: 17034957 [TBL] [Abstract][Full Text] [Related]
4. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
5. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration. Yang B; Ali SZ; Rosenthal DL Diagn Cytopathol; 2002 Sep; 27(3):149-52. PubMed ID: 12203861 [TBL] [Abstract][Full Text] [Related]
6. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050 [TBL] [Abstract][Full Text] [Related]
7. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184 [TBL] [Abstract][Full Text] [Related]
8. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094 [TBL] [Abstract][Full Text] [Related]
9. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311 [TBL] [Abstract][Full Text] [Related]
10. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617 [TBL] [Abstract][Full Text] [Related]
11. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases]. Liu LN; Chen GY; Wang P; Zhang CH; Huang SF Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571 [TBL] [Abstract][Full Text] [Related]
14. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753 [TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study. Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592 [TBL] [Abstract][Full Text] [Related]
16. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780 [TBL] [Abstract][Full Text] [Related]
17. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy. Simsir A; Chhieng D; Wei XJ; Yee H; Waisman J; Cangiarella J Diagn Cytopathol; 2005 Jul; 33(1):3-7. PubMed ID: 15945081 [TBL] [Abstract][Full Text] [Related]
18. Expression of S-100 protein in renal cell neoplasms. Lin F; Yang W; Betten M; Teh BT; Yang XJ; Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922 [TBL] [Abstract][Full Text] [Related]
19. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma. Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]